Literature DB >> 1417191

Intestinal radioprotection by two new agents applied topically.

J P Delaney1, M Bonsack, P Hall.   

Abstract

The purpose of this study was to test two novel antioxidant drugs, each capable of inhibiting membrane peroxidation and of free radical scavenging, as topical radioprotectants for the intestine. A loop of rat midintestine was exteriorized and radiated while the remainder of the animal was protected in a lead box. The intestine was first compartmentalized and each segment filled with a test solution. Radiated segments of intestine were compared, drug filled with vehicle filled, and both with normal unradiated intestine. The animals were killed 5 days after 1100 cGy radiation to the exteriorized loop. Crypt numbers and mucosal height were used as the measures of injury protection. On the basis of crypt numbers, the 21-amino steroid (U-74500A) gave approximately 40% and the vitamin E-like compound (U-78518F) gave 60% reduction in crypt loss. The authors conclude that lumenal antioxidant drugs can provide partial protection of the intestinal mucosa from acute radiation damage and that these two specific agents are effective and potentially useful.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1417191      PMCID: PMC1242642          DOI: 10.1097/00000658-199210000-00004

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  20 in total

1.  The influence of lumenal pH on the severity of acute radiation enteritis.

Authors:  J P Delaney; G E Kimm; M E Bonsack
Journal:  Int J Radiat Biol       Date:  1992-03       Impact factor: 2.694

2.  Novel 21-amino steroids as potent inhibitors of iron-dependent lipid peroxidation.

Authors:  J M Braughler; J F Pregenzer; R L Chase; L A Duncan; E J Jacobsen; J M McCall
Journal:  J Biol Chem       Date:  1987-08-05       Impact factor: 5.157

3.  Changes in the rat intestine after x-irradiation of exteriorized short segments of ileum.

Authors:  J W Osborne; K N Prasad; G R Zimmerman
Journal:  Radiat Res       Date:  1970-07       Impact factor: 2.841

4.  Protective effects of a novel nonglucocorticoid 21-aminosteroid (U74006F) during traumatic shock in rats.

Authors:  N Aoki; A M Lefer
Journal:  J Cardiovasc Pharmacol       Date:  1990-02       Impact factor: 3.105

5.  Effects of U74006F, a novel inhibitor of lipid peroxidation, in stunned reperfused canine myocardium.

Authors:  H H Holzgrefe; L V Buchanan; J K Gibson
Journal:  J Cardiovasc Pharmacol       Date:  1990-02       Impact factor: 3.105

Review 6.  The radiolabeled microsphere technique in gut blood flow measurement--current practice.

Authors:  B A Levine; K R Sirinek; H V Gaskill
Journal:  J Surg Res       Date:  1984-09       Impact factor: 2.192

7.  Influence of intestinal content on radiation lesions of the small intestine.

Authors:  N Hiatt; N E Warner
Journal:  Proc Soc Exp Biol Med       Date:  1967-03

8.  Intracolonic WR 2721 protection of the rat colon from acute radiation injury.

Authors:  H G France; R L Jirtle; C M Mansbach
Journal:  Gastroenterology       Date:  1986-09       Impact factor: 22.682

9.  The 21-aminosteroid inhibitors of lipid peroxidation: reactions with lipid peroxyl and phenoxy radicals.

Authors:  J M Braughler; J F Pregenzer
Journal:  Free Radic Biol Med       Date:  1989       Impact factor: 7.376

10.  The role of luminal contents in radiation enteritis.

Authors:  M W Mulholland; S H Levitt; C W Song; R A Potish; J P Delaney
Journal:  Cancer       Date:  1984-12-01       Impact factor: 6.860

View more
  2 in total

1.  Intestinal radioprotection by vitamin E (alpha-tocopherol).

Authors:  I Felemovicius; M E Bonsack; M L Baptista; J P Delaney
Journal:  Ann Surg       Date:  1995-10       Impact factor: 12.969

2.  Effect of preinduction of heat-shock proteins on acetic acid-induced small intestinal lesions in rats.

Authors:  H Sasahara; M Otaka; S Itoh; A Iwabuchi; M Odashima; I Wada; N Konishi; I I Pacheco; Y Tashima; H Itoh; S Otani; O Masamune
Journal:  Dig Dis Sci       Date:  1998-09       Impact factor: 3.199

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.